Review article: infliximab for Crohn’s disease treatment – shifting therapeutic strategies after 10?years of clinical experience

S. Danese; J.-F. Colombel; W. Reinisch; P. J. Rutgeerts

首页> 外文期刊>Alimentary Pharmacology & Therapeutics >Review article: infliximab for Crohn’s disease treatment – shifting therapeutic strategies after 10?years of clinical experience

【24h】

Review article: infliximab for Crohn’s disease treatment – shifting therapeutic strategies after 10?years of clinical experience

机译：评论文章：英夫利昔单抗用于克罗恩病治疗–经过10年临床经验后改变治疗策略

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aliment Pharmacol Ther 2011; 33: 857–869

机译：Aliment Pharmacol Ther 2011； 33：857–869

著录项

来源
《Alimentary Pharmacology & Therapeutics》 |2011年第8期|857-869|共13页
作者
S. Danese; J.-F. Colombel; W. Reinisch; P. J. Rutgeerts;
展开▼
作者单位

Division of Gastroenterology Instituto Clinico Humanitas IRCCS in Gastroenterology Milan Italy.;

Department of Hepato-Gastroenterology Hospital Huriez Lille France.;

Abteilung Gastroenterologie und Hepatologie Universittsklinik Innere Medizin III Vienna Austria.;

Department of Gastroenterology University Hospitals Leuven Leuven Belgium.;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Review article: infliximab for Crohn's disease treatment--shifting therapeutic strategies after 10 years of clinical experience. [J] . Danese S, Colombel JF, Reinisch W, Alimentary pharmacology & therapeutics. . 2011,第8期

机译：综述文章：英夫利昔单抗用于克罗恩病的治疗-经过10年临床经验后改变治疗策略。
2. Changes in Serum Trough Levels of Infliximab During Treatment Intensification but not in Anti-infliximab Antibody Detection are Associated with Clinical Outcomes after Therapeutic Failure in Crohn's Disease [J] . Steenholdt Casper, Bendtzen Klaus, Brynskov Jorn, Journal of Crohn’s & colitis . 2015,第3期

机译：克罗恩病治疗失败后，在强化治疗过程中英夫利昔单抗血清谷水平的变化与抗英夫利昔单抗抗体检测中的变化不相关
3. Infliximab in clinical routine: experience with Crohn's disease and biomarkers of inflammation over 5 years. [J] . Lonnkvist MH, Befrits R, Lundberg JO European journal of gastroenterology and hepatology . 2009,第10期

机译：英夫利昔单抗的临床常规治疗：5年以上的克罗恩病和炎症生物标志物经验。
4. The use of the low level laser therapy (LLLT) in the treatment of some pulmonary diseases (10-years experience) [C] . V.A.Derbenjev, V.A.Mikhailov, I.N.Denisov Conference on Laser Florence'99: A Window on the Laser Medicine World 28-31 October 1999 Florence, Italy . 1999

机译：使用低水平激光疗法（LLLT）治疗某些肺部疾病（已有10年的经验）
5. A Cost-utility Analysis of Biosimilar Infliximab Compared to Reference Infliximab in Adult Switch Patients with Crohn's Disease: A Canadian Analysis [D] . Hughes, Avery. 2018

机译：生物纤维生素infiximab的成本实用性分析与成人交换患者参考incriximab患者克罗恩病患者：加拿大分析
6. Treatment of recurrent cerebrovascular disease. Review of a 10-year experience. [O] . K A Coyle, R B Smith 3rd, B C Gray, 1995

机译：治疗复发性脑血管疾病。回顾十年的经验。
7. Review Article: Infliximab for Crohn's disease treatment: shifting therapeutic strategies after 10 years of clinical experience [O] . Danese, Silvio, Colombel, Jean-Frédéric, Reinisch, Walter, 2011

机译：综述文章：英夫利昔单抗用于克罗恩病治疗：十年临床经验后改变治疗策略

Review article: infliximab for Crohn’s disease treatment – shifting therapeutic strategies after 10?years of clinical experience

摘要

著录项

相似文献

相关主题

期刊订阅